| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
561 |
257 |
$294K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,422 |
2,948 |
$196K |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
124 |
68 |
$104K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,762 |
1,370 |
$99K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
62 |
51 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,935 |
1,579 |
$71K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
768 |
689 |
$70K |
| 96415 |
|
1,112 |
858 |
$18K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
721 |
548 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
204 |
164 |
$5K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
595 |
442 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
752 |
417 |
$440.10 |
| 36415 |
Collection of venous blood by venipuncture |
206 |
168 |
$183.38 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
51 |
35 |
$76.89 |
| J7050 |
Infusion, normal saline solution, 250 cc |
63 |
43 |
$13.92 |